China to use COVID-19 vaccine by end of year even if trials not completed
The reason for this decision is because of the dwindling number of new coronavirus cases in China.
Vial 1 of Box 1. This is the vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020(photo credit: SEAN ELIAS/HANDOUT VIA REUTERS)ByAARON REICH
